Joel Ackerman
Management
Good morning. I am Joel Ackerman, the CEO of Champions Oncology. Thank you for joining us for our quarterly earnings call. I will start the call today with highlights and update since our last call, then discuss the financial results and then open up the call for questions. Before I start, I will remind you that I will be making forward-looking statements during the call and actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available in our Forms 10-Q and 10-K. Reconciliation of the non-GAAP financial measures that may be discussed on the call to GAAP financial measures is available in the earnings release. Overall, this was a great quarter for Champions. We are laser focused on executing on our strategy, and I have never been as excited about the direction we are heading. The market potential is huge. We are really well positioned, and the progress is tangible. Both the actual financial results and the leading indicators of future growth are really progressing well. As you will hear, we are growing our top line, managing our expenses and on path to cash flow positive. With that backdrop, let me talk about some of the specific highlights of the quarter. I will start today with bookings; there is no single number that predicts future revenue growth, but bookings comes as close as any metric we follow. While we do not disclose specific details, I can tell you that this was a very strong quarter for us. Core POS bookings, the main driver of our revenue and growth, broke our previous single quarter record. It was also a well balanced quarter, with a healthy mix of business from repeat customers and new customers. Our sales team…